These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 36522665

  • 1. Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.
    Wang L, Lu Y, Dai Z, Shi P, Xu J, Chang F, Lu Y.
    Health Qual Life Outcomes; 2022 Dec 15; 20(1):164. PubMed ID: 36522665
    [Abstract] [Full Text] [Related]

  • 2. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K, BADBIR Study Group.
    Value Health; 2018 Aug 15; 21(8):1010-1018. PubMed ID: 30098665
    [Abstract] [Full Text] [Related]

  • 3. Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.
    Yu L, Yang H, Lu L, Fang Y, Zhang X, Li S, Li C.
    Health Qual Life Outcomes; 2024 Aug 07; 22(1):61. PubMed ID: 39113080
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD, de Hond A, Degeling K, Punt CJA, Koopman M, Uyl-de Groot CA, Versteegh MM, van Oijen MGH.
    Health Qual Life Outcomes; 2020 Jul 20; 18(1):240. PubMed ID: 32690011
    [Abstract] [Full Text] [Related]

  • 5. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G, Garcia-Gordillo MA, Collado-Mateo D, Del Pozo-Cruz B, Adsuar JC, Cordero-Ferrera JM, Abellán-Perpiñán JM, Sánchez-Martínez FI.
    Patient; 2018 Dec 20; 11(6):665-675. PubMed ID: 29876865
    [Abstract] [Full Text] [Related]

  • 6. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK, Tabberer M, Brooks J.
    Value Health; 2016 Jun 20; 19(4):469-77. PubMed ID: 27325339
    [Abstract] [Full Text] [Related]

  • 7. Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study.
    Camacho EM, Shields GE, Chew-Graham CA, Eisner E, Gilbody S, Littlewood E, McMillan D, Watson K, Fearon P, Sharp DJ.
    Eur J Health Econ; 2024 Mar 20; 25(2):319-332. PubMed ID: 37093502
    [Abstract] [Full Text] [Related]

  • 8. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
    Yang Q, Yu XX, Zhang W, Li H.
    Health Qual Life Outcomes; 2019 Oct 15; 17(1):153. PubMed ID: 31615531
    [Abstract] [Full Text] [Related]

  • 9. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA, Wailoo AJ, Hernandez Alava M.
    Value Health; 2018 Dec 15; 21(12):1399-1405. PubMed ID: 30502783
    [Abstract] [Full Text] [Related]

  • 10. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A, Young CA, Hughes DA.
    Value Health; 2018 Nov 15; 21(11):1322-1329. PubMed ID: 30442280
    [Abstract] [Full Text] [Related]

  • 11. Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.
    Inotai A, Nagy D, Kaló Z, Vokó Z.
    Qual Life Res; 2024 Sep 15; 33(9):2417-2428. PubMed ID: 38839684
    [Abstract] [Full Text] [Related]

  • 12. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
    Grochtdreis T, Brettschneider C, Hajek A, Schierz K, Hoyer J, Koenig HH.
    J Ment Health Policy Econ; 2016 Jun 15; 19(2):79-89. PubMed ID: 27453455
    [Abstract] [Full Text] [Related]

  • 13. Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility.
    Park SY, Park EJ, Suh HS, Ha D, Lee EK.
    J Eval Clin Pract; 2017 Aug 15; 23(4):755-761. PubMed ID: 28194852
    [Abstract] [Full Text] [Related]

  • 14. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J, Khan KA, Petrou S, Lamb SE.
    Pharmacoeconomics; 2017 May 15; 35(5):549-559. PubMed ID: 28063083
    [Abstract] [Full Text] [Related]

  • 15. Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study.
    Castro R, De Boni RB, Perazzo H, Grinsztejn B, Veloso VG, Ribeiro-Alves M.
    Qual Life Res; 2020 Sep 15; 29(9):2497-2508. PubMed ID: 32451983
    [Abstract] [Full Text] [Related]

  • 16. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
    Doble B, Lorgelly P.
    Qual Life Res; 2016 Apr 15; 25(4):891-911. PubMed ID: 26391884
    [Abstract] [Full Text] [Related]

  • 17. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.
    Joyce VR, Sun H, Barnett PG, Bansback N, Griffin SC, Bayoumi AM, Anis AH, Sculpher M, Cameron W, Brown ST, Holodniy M, Owens DK.
    MDM Policy Pract; 2017 Apr 15; 2(2):2381468317716440. PubMed ID: 30288427
    [Abstract] [Full Text] [Related]

  • 18. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
    Yang F, Wong CKH, Luo N, Piercy J, Moon R, Jackson J.
    Eur J Health Econ; 2019 Nov 15; 20(8):1195-1206. PubMed ID: 31338698
    [Abstract] [Full Text] [Related]

  • 19. Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.
    Woodcock F, Doble B, CANCER 2015 Consortium.
    Med Decis Making; 2018 Nov 15; 38(8):954-967. PubMed ID: 30226101
    [Abstract] [Full Text] [Related]

  • 20. Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer.
    Gray LA, Hernandez Alava M, Wailoo AJ.
    BMC Cancer; 2021 Nov 18; 21(1):1237. PubMed ID: 34794404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.